The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Adaptimmune Therapeutics plc Sponsored ADR 00653A107   3,974,811 5,095,912 SH   SOLE   5,095,912 0 0
Amicus Therapeutics Inc. Common 03152W109   8,708,250 716,139 SH   SOLE   716,139 0 0
Avadel Pharmaceuticals PLC Common 05337M104   6,841,507 664,224 SH   SOLE   664,224 0 0
Axsome Therapeutics, Inc. Common 05464T104   6,540,726 93,586 SH   SOLE   93,586 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107   14,247,036 479,053 SH   SOLE   479,053 0 0
Cullinan Oncology, Inc. Common 230031106   69,216,825 7,648,268 SH   SOLE   7,648,268 0 0
CYMABAY THERAPEUTICS INC Common 23257D103   9,106,581 610,770 SH   SOLE   610,770 0 0
Geron Corporation Common 374163103   22,710,460 10,712,481 SH   SOLE   10,712,481 0 0
Harpoon Therapeutics, Inc. Common 41358P205   1,288,270 319,670 SH   SOLE   319,670 0 0
Inozyme Pharma Inc. Common 45790W108   1,373,068 326,921 SH   SOLE   326,921 0 0
Insmed Incorporated Common 457669307   13,318,315 527,458 SH   SOLE   527,458 0 0
Kalvista Pharmaceuticals Inc Common 483497103   5,565,736 577,958 SH   SOLE   577,958 0 0
Karuna Therapeutics Inc Common 48576A100   8,997,279 53,210 SH   SOLE   53,210 0 0
Intellia Therapeutics, Inc. Common 45826J105   17,221,485 544,639 SH   SOLE   544,639 0 0
Iovance Biotherapeutics Inc Common 462260100   14,957,656 3,287,397 SH   SOLE   3,287,397 0 0
iTeos Therapeutics, Inc. Common 46565G104   19,118,076 1,745,943 SH   SOLE   1,745,943 0 0
Madrigal Pharmaceuticals inc Common 558868105   5,967,048 40,859 SH   SOLE   40,859 0 0
Moonlake Immunotherapeutics Common 61559X104   16,768,830 294,190 SH   SOLE   294,190 0 0
MORPHIC HOLDING INC Common 61775R105   4,582,000 200,000 SH   SOLE   200,000 0 0
Olema Pharmaceuticals, Inc. Common 68062P106   22,942,360 1,857,681 SH   SOLE   1,857,681 0 0
Phathom Pharmaceuticals inc Common 71722W107   3,601,833 347,332 SH   SOLE   347,332 0 0
REGENXBIO Inc. Common 75901B107   10,809,578 656,718 SH   SOLE   656,718 0 0
Relay Therapeutics Inc. Common 75943R102   11,371,439 1,352,133 SH   SOLE   1,352,133 0 0
Repare Therapeutics, Inc. Common 760273102   19,809,376 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100   7,567,933 273,408 SH   SOLE   273,408 0 0
STRUCTURE THERAPEUTICS INC Common 86366E106   11,634,970 230,761 SH   SOLE   230,761 0 0
Travere Therapeutics Inc. Common 89422G107   4,942,443 552,846 SH   SOLE   552,846 0 0
Verve Therapeutics, Inc Common 92539P101   11,376,284 857,940 SH   SOLE   857,940 0 0
VIKING THERAPEUTICS INC Common 92686J106   3,597,750 325,000 SH   SOLE   325,000 0 0
Viridian Therapeutics Inc Common 92790C104   3,916,655 255,323 SH   SOLE   255,323 0 0
Xeris Biopharma Holdings Inc Common 98422E103   7,417,619 3,987,967 SH   SOLE   3,987,967 0 0
Werewolf Therapeutics, Inc. Common 95075A107   5,110,344 2,388,011 SH   SOLE   2,388,011 0 0